The Board of Sparc Electrex at its meeting held on 23 September 2022 has approved the issuance of equity shares up to Rs 30 crore by way of rights issue
Aarti Industries announced that National Company Law Tribunal has on 22 September 2022 approved the Scheme of Arrangement between Aarti Industries and Aarti Pharmalabs and their respective shareholders under the provisions of Section 230-232 of Companies Act 2013
Gretex Corporate Services announced that the Annual General Meeting AGM of the company will be held on 30 September 2022
Kwality Pharmaceuticals announced that the Annual General Meeting AGM of the company will be held on 30 September 2022
Kshitij Investments announced that the Annual General Meeting AGM of the company will be held on 29 September 2022
Elgi Equipments has received reaffirmation in credit ratings from CRISIL for bank facilities aggregating Rs 456 crore availed by the company as under Long term bank facilities – CRISIL AA Stable Short term bank facilities – CRISIL A1
Housing Development Finance Corporation has allotted 747528 equity shares of Rs 2 each of the Corporation under ESOS on 23 September 2022 Post the above allotment the paid-up share capital of the Corporation is Rs 3634077774 consisting of 1817038887 equity shares of Rs 2 each
SEPC announced the resignation of T Shivaraman Managing Director CEO and Mohammed Amjat Sharif Joint Managing Director from the board of the company with effect from 19 September 2022 Further P D Karandikar Independent Director Chairperson on board of the company also resigned with effect from 22 September 2022
Bausch Health Companies Inc Bausch Health and Glenmark Specialty SA a subsidiary of Glenmark Pharmaceuticals Glenmark announced that RYALTRIS olopatadine hydrochloride and mometasone furoate nasal spray has been approved by Health Canada for the symptomatic treatment of moderate to severe seasonal allergic rhinitis SAR and associated ocular symptoms in adults adolescents and children aged 6 years and older RYALTRIS is a fixed-dose combination therapy that […]
Cian Healthcare will hold a meeting of the Board of Directors of the Company on 26 September 2022
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
